X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3621) 3621
Newsletter (489) 489
Publication (236) 236
Book Review (56) 56
Book Chapter (17) 17
Newspaper Article (10) 10
Conference Proceeding (4) 4
Book / eBook (1) 1
Dissertation (1) 1
Magazine Article (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
tacrolimus (3181) 3181
humans (2782) 2782
transplantation (2410) 2410
male (1933) 1933
index medicus (1867) 1867
female (1840) 1840
adult (1466) 1466
middle aged (1457) 1457
immunosuppressive agents - therapeutic use (1258) 1258
surgery (1162) 1162
cyclosporine (1067) 1067
tacrolimus - therapeutic use (1046) 1046
kidney transplantation (968) 968
kidneys (942) 942
pharmacology & pharmacy (878) 878
immunosuppressive agents - pharmacokinetics (853) 853
immunosuppressive agents - administration & dosage (804) 804
tacrolimus - administration & dosage (791) 791
pharmacokinetics (770) 770
immunology (752) 752
tacrolimus - pharmacokinetics (732) 732
recipients (679) 679
organ transplant recipients (675) 675
immunosuppression (658) 658
aged (592) 592
immunosuppressive agents - adverse effects (564) 564
graft rejection - prevention & control (542) 542
analysis (534) 534
research (528) 528
liver (527) 527
treatment outcome (525) 525
adolescent (508) 508
immunosuppressive agents - blood (505) 505
calcineurin inhibitors (495) 495
liver transplantation (486) 486
tacrolimus - blood (485) 485
retrospective studies (482) 482
tacrolimus - adverse effects (458) 458
drug therapy, combination (453) 453
cyclosporine - therapeutic use (424) 424
mycophenolic acid - analogs & derivatives (403) 403
medical research (402) 402
transplants & implants (400) 400
health aspects (383) 383
time factors (382) 382
medicine, experimental (380) 380
child (379) 379
immunosuppressive agents (350) 350
fk506 (346) 346
transplantation of organs, tissues, etc (341) 341
kidney-transplantation (340) 340
kidney transplantation - immunology (337) 337
immunotherapy (336) 336
follow-up studies (335) 335
dose-response relationship, drug (331) 331
renal-transplantation (329) 329
mycophenolate-mofetil (326) 326
young adult (326) 326
risk factors (317) 317
sirolimus (314) 314
prospective studies (313) 313
pediatrics (307) 307
pharmacogenetics (300) 300
mycophenolate mofetil (298) 298
therapy (295) 295
mycophenolic acid - therapeutic use (294) 294
genotype (290) 290
area under curve (288) 288
acute rejection (285) 285
cytochrome p-450 cyp3a - genetics (281) 281
rejection (279) 279
drug interactions (264) 264
graft rejection (257) 257
animals (255) 255
child, preschool (244) 244
fk-506 (243) 243
medicine & public health (241) 241
cyclosporine-a (237) 237
urology & nephrology (237) 237
immunosuppressive agents - pharmacology (236) 236
graft survival (228) 228
cyp3a5 (227) 227
children (224) 224
kidney transplantation - adverse effects (221) 221
renal transplantation (217) 217
genetic aspects (209) 209
tacrolimus - pharmacology (209) 209
metabolism (208) 208
dosage and administration (207) 207
drug monitoring (207) 207
graft rejection - drug therapy (205) 205
efficacy (203) 203
drugs (194) 194
mycophenolic acid (194) 194
reports (194) 194
patients (192) 192
mycophenolic acid - pharmacokinetics (190) 190
p-glycoprotein (187) 187
cyclosporine - administration & dosage (184) 184
drug administration schedule (183) 183
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Internal Medicine Journal, ISSN 1444-0903, 01/2019, Volume 49, Issue 1, pp. 79 - 83
Background Tacrolimus is one of the most widely used liver transplant medications. With the increasing number of obese patients requiring liver transplants,... 
pharmacokinetics | body size | liver transplant | tacrolimus | WHOLE-BLOOD | MEDICINE, GENERAL & INTERNAL | PHARMACODYNAMICS | FK-506 | LEVEL | CLINICAL PHARMACOKINETICS | Plasma | Allografts | Transplants & implants | Tacrolimus | Syngeneic grafts | Body size | Liver | Blood levels | Liver transplantation
Journal Article
Journal of Clinical Pharmacy and Therapeutics, ISSN 0269-4727, 06/2019, Volume 44, Issue 3, pp. 409 - 414
Summary What is known and objective The target trough concentration of tacrolimus for ulcerative colitis is recommended to be 10‐15 ng/mL in the initial two... 
administration method | serum concentration | early improvement | tacrolimus | ORAL TACROLIMUS | CYTOCHROME-P450 3A5 | INDUCTION THERAPY | EFFICACY | SAFETY | DISEASE | PHARMACOLOGY & PHARMACY | FK506 | Evaluation | Care and treatment | Tacrolimus | Ulcerative colitis | Inflammatory bowel disease | Signs and symptoms | Colon | Dosage | Patients | Blood levels
Journal Article
European Journal of Clinical Pharmacology, ISSN 0031-6970, 3/2016, Volume 72, Issue 3, pp. 277 - 283
Journal Article
Journal Article
Transplantation Proceedings, ISSN 0041-1345, 10/2018, Volume 50, Issue 8, pp. 2401 - 2403
Background: The online percent coefficient of variation reporting system could monitor the variation of tacrolimus trough level (T ) and identify kidney... 
SURGERY | RISK | IMMUNOLOGY | TRANSPLANTATION | Tacrolimus - therapeutic use | Immunosuppressive Agents - blood | Tacrolimus - blood | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Adult | Female | Male | Research Design - standards | Online Systems | Kidney Transplantation - methods | Organ transplant recipients | Transplantation | Kidneys | Tacrolimus | Statistics
Journal Article
Clinical and Experimental Nephrology, ISSN 1342-1751, 10/2017, Volume 21, Issue 5, pp. 787 - 796
We investigated the impact of the CYP3A5 genotype on the distributions of dose-adjusted trough concentrations (C 0h/D) and the incidence of rejection in... 
Rejection | Nephrology | Medicine & Public Health | Tacrolimus | Formulation | Renal transplantation | CYP3A5 genotype | Dose-adjusted trough concentration | Urology | POPULATION | DETERMINANTS | TWICE-DAILY TACROLIMUS | INTRAPATIENT VARIABILITY | PHARMACODYNAMICS | PHARMACOKINETICS | KIDNEY-TRANSPLANTATION | UROLOGY & NEPHROLOGY | ABCB1 POLYMORPHISMS | PHARMACOGENETICS | SINGLE NUCLEOTIDE POLYMORPHISMS | Japan - epidemiology | Multivariate Analysis | Calcineurin Inhibitors - pharmacokinetics | Humans | Immunosuppressive Agents - pharmacokinetics | Asian Continental Ancestry Group - genetics | Incidence | Calcineurin Inhibitors - blood | Drug Dosage Calculations | Immunosuppressive Agents - blood | Cytochrome P-450 CYP3A - genetics | Drug Compounding | Pharmacogenomic Variants | Odds Ratio | Immunosuppressive Agents - administration & dosage | Tacrolimus - administration & dosage | Pharmacogenetics | Calcineurin Inhibitors - administration & dosage | Graft Rejection - prevention & control | Risk Factors | Genotype | Logistic Models | Treatment Outcome | Tacrolimus - pharmacokinetics | Chi-Square Distribution | Tacrolimus - adverse effects | Calcineurin Inhibitors - adverse effects | Cytochrome P-450 CYP3A - metabolism | Graft Rejection - ethnology | Immunosuppressive Agents - adverse effects | Graft Rejection - immunology | Drug Monitoring | Graft Rejection - genetics | Graft Survival - drug effects | Kidney Transplantation - adverse effects | Kidneys | Analysis | Organ transplant recipients | Genetic aspects | Transplantation | Kidney diseases | Transplants & implants | Alleles | Health risk assessment | Gene polymorphism | Graft rejection | Kidney transplantation
Journal Article